Edinburgh Research Explorer

An evaluation of the emerging vaccines and immunotherapy against staphylococcal pneumonia in children

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Documents

  • Download as Adobe PDF

    Rights statement: © 2011 Huda et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Final published version, 428 KB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

http://www.biomedcentral.com/1471-2458/11/S3/S27
Original languageEnglish
Pages (from-to)S27
JournalBMC Public Health
Volume11 Suppl 3
DOIs
Publication statusPublished - 2011

Abstract

Staphylococcus aureus is a commensal of human skin and nares. It is also one of the leading nosocomial pathogens in both developed and developing countries and is responsible for a wide range of life threatening infections, especially in patients who are immunocompromised, post-surgery, undergoing haemodialysis and those who are treated with catheters and ventilators. Over the past two decades, the incidence of nosocomial staphylococcal infections has increased dramatically. Currently there are at least seven vaccine and immunotherapy candidates against S. aureus in the developmental phase targeting both active and passive immunization.

Download statistics

No data available

ID: 3460180